Aerpio Therapeutics' Series B Round

Aerpio Therapeutics raised a round of funding on April 23, 2014.

Aerpio Therapeutics is a clinical‐stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. Aerpio is a leader in the development of small molecule drugs based…

Articles about Aerpio Therapeutics' Series B Round: